JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.03% |
| 2 | Healthcare | 9.24% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Financials | 8.61% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
AdvanSix
ASIX
$460M
| $2.09M | ﹤0.01% |
91,268
-12,410
| -12% | -$309K |
|
3602
FTAI Infrastructure
FIP
$533M
| $2.09M | ﹤0.01% |
242,391
+41,668
| +21% | +$318K |
|
3603
AMC Global Media
AMCX
$510M
| $2.09M | ﹤0.01% |
216,052
-28,110
| -12% | -$371K |
|
3604
PUT
Biogen
BIIB
$31B
| $2.09M | ﹤0.01% |
9,000
| – | – |
|
3605
Celldex Therapeutics
CLDX
$3.29B
| $2.09M | ﹤0.01% |
56,364
+9,609
| +21% | +$363K |
|
3606
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$140M
| $2.08M | ﹤0.01% |
47,564
+12,728
| +37% | +$634K |
|
|
OSG
3607
Octave Specialty Group
OSG
$221M
| $2.08M | ﹤0.01% |
161,972
+20,848
| +15% | +$318K |
|
3608
PUT
Marvell Technology
MRVL
$199B
| $2.08M | ﹤0.01% |
29,700
-46,100
| -61% | -$3.23M |
|
3609
indie Semiconductor
INDI
$995M
| $2.07M | ﹤0.01% |
335,618
+9,606
| +3% | +$61.1K |
|
3610
Eagle Bancorp
EGBN
$878M
| $2.07M | ﹤0.01% |
109,505
-60,157
| -35% | -$1.17M |
|
3611
Peloton Interactive
PTON
$2.47B
| $2.06M | ﹤0.01% |
610,898
+180,969
| +42% | +$648K |
|
3612
Cheesecake Factory
CAKE
$5.64B
| $2.06M | ﹤0.01% |
52,554
-3,373
| -6% | -$125K |
|
3613
Schwab Municipal Bond ETF
SCMB
$3.98B
| $2.06M | ﹤0.01% |
80,282
+72,104
| +882% | +$1.86M |
|
3614
CALL
Nutrien
NTR
$32.6B
| $2.06M | ﹤0.01% |
40,400
-1,100
| -3% | -$60.2K |
|
3615
Enanta Pharmaceuticals
ENTA
$383M
| $2.06M | ﹤0.01% |
158,546
+20,499
| +15% | +$277K |
|
|
TSVT
3616
DELISTED
2seventy bio
TSVT
| $2.05M | ﹤0.01% |
532,432
-431,280
| -45% | -$1.94M |
|
3617
The RealReal
REAL
$1.39B
| $2.04M | ﹤0.01% |
640,919
+78,304
| +14% | +$289K |
|
3618
CALL
Lucid Motors
LCID
$2.45B
| $2.04M | ﹤0.01% |
78,290
-88,870
| -53% | -$2.37M |
|
3619
MacroGenics
MGNX
$268M
| $2.04M | ﹤0.01% |
480,261
-548,788
| -53% | -$5.34M |
|
3620
Credit Acceptance
CACC
$6.1B
| $2.04M | ﹤0.01% |
3,964
-15,689
| -80% | -$7.99M |
|
3621
Innovator US Equity Power Buffer ETF January
PJAN
$1.43B
| $2.04M | ﹤0.01% |
50,632
+27,117
| +115% | +$1.07M |
|
3622
Vanguard Russell 2000 Growth ETF
VTWG
$1.57B
| $2.04M | ﹤0.01% |
10,658
-330
| -3% | -$62.3K |
|
3623
Universal Insurance Holdings
UVE
$1.2B
| $2.04M | ﹤0.01% |
108,482
+25,416
| +31% | +$494K |
|
3624
Zentalis Pharmaceuticals
ZNTL
$255M
| $2.03M | ﹤0.01% |
495,810
+437,189
| +746% | +$4.88M |
|
3625
Avantis All International Markets Equity ETF
AVNM
$726M
| $2.03M | ﹤0.01% |
36,222
-20,167
| -36% | -$1.14M |
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,512 increased, 3,286 reduced and 579 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 579 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.